Recent NCNA News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/16/2024 10:05:26 AM
- NuCana Presents Encouraging Data on NUC-7738 in Combination with Pembrolizumab in PD-1 Inhibitor Refractory and Resistant Melanoma Patients at the ESMO Congress 2024 • GlobeNewswire Inc. • 09/14/2024 07:01:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/29/2024 08:17:27 PM
- NuCana Announces Update for Phase 2 Randomized Colorectal Cancer Study • GlobeNewswire Inc. • 08/29/2024 08:01:00 PM
- Form F-3 - Registration statement by foreign private issuers • Edgar (US Regulatory) • 08/15/2024 08:35:24 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/15/2024 08:09:05 PM
- NuCana Reports Second Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/15/2024 08:01:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/18/2024 08:02:56 PM
- NuCana to Present at the Jefferies Global Healthcare Conference • GlobeNewswire Inc. • 05/30/2024 12:36:30 PM
- NuCana to Present at TD Cowen’s 5th Annual Oncology Innovation Summit • GlobeNewswire Inc. • 05/21/2024 12:00:05 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/16/2024 08:11:50 PM
- NuCana Reports First Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/16/2024 08:01:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/13/2024 08:13:55 PM
- NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement • GlobeNewswire Inc. • 05/01/2024 08:01:00 PM
- NuCana Announces Completion of ADS Ratio Change • GlobeNewswire Inc. • 04/16/2024 12:00:00 PM
- NuCana Presents Data at the AACR 2024 Annual Meeting Highlighting the Ability of NUC-7738 to Profoundly Alter Tumor Biology in a Paired Biopsy Clinical Study • GlobeNewswire Inc. • 04/09/2024 08:30:00 PM
- NuCana Announces Plan to Implement ADS Ratio Change • GlobeNewswire Inc. • 03/27/2024 08:30:00 PM
- NuCana Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 03/20/2024 08:01:00 PM
- NuCana to Present at TD Cowen’s 44th Annual Health Care Conference • GlobeNewswire Inc. • 02/27/2024 01:00:00 PM
- NuCana to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference • GlobeNewswire Inc. • 02/06/2024 01:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/16/2023 09:08:52 PM
- NuCana Reports Third Quarter 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 11/16/2023 09:01:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/13/2023 09:22:50 PM
- NuCana Announces Listing Transfer to Nasdaq Capital Market • GlobeNewswire Inc. • 11/10/2023 09:01:00 PM
- NuCana to Present at the Jefferies London Healthcare Conference • GlobeNewswire Inc. • 11/08/2023 09:01:00 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM